Skip to main content
. 2017 Sep 25;53(4):557–565. doi: 10.1007/s00535-017-1391-5

Fig. 1.

Fig. 1

Study design for GT1-infected DAA-naïve patients enrolled and treated in the CERTAIN-1 study (Arm C included other patient cohorts reported elsewhere)